Changing face of pulmonary embolism with COVID-19

Bagirtan B., Altuntas E., Yasar S., Karabay K. O.

CARDIOVASCULAR JOURNAL OF AFRICA, cilt.34, sa.1, ss.4-8, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 1
  • Basım Tarihi: 2023
  • Doi Numarası: 10.5830/cvja-2022-011
  • Dergi Adı: CARDIOVASCULAR JOURNAL OF AFRICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.4-8
  • Kocaeli Üniversitesi Adresli: Hayır

Özet

Aim: This study aimed to describe the baseline characteristics of coronavirus disease 2019 (COV1D-19) patients with pulmonary embolism, and to examine the Geneva score, pulmonary embolism severity index (PESO, radiological and biochemical findings. Methods: From March 2020 to June 2021, the files of 41 COVID-19 patients with pulmonary embolism were accessed. Results: Mean D-dimer value was 6.04 mg/dl and 61% of the patients received at least one dose of anticoagulant treatment. In patients receiving deep venous thrombosis prophlaxis. an optimal D-dimer cut-off point was calculated as 5.69 mg/dl. The area under the curve was 0.753 (p = 0.007; sensivity 64%: specificity 62.5%). The mean Geneva score was 4.31, mean PESI was 72.48 and mean Qanadli score was 11.29. Conclusions: According to this study. traditional clinical predictive scores had little discriminatory power in these patients, and a higher D-dimer cut-off value should he considered to better diagnose patients for pulmonary embolism.